Alliance for Clinical Trials in Oncology
New trial — Genetic Testing in Guiding Treatment for Patients With Brain Metastases
New trial
59/100
Opportunity
Commercial fit12/25
Clinical timing20/20
Biomarker need10/20
Relationship2/10
Signal strength9/10
Account value5/10
Urgency1/5
New phase 2 trial NCT03994796 posted by Alliance for Clinical Trials in Oncology: "Genetic Testing in Guiding Treatment for Patients With Brain Metastases". New trial on a phase 2 active not recruiting study is a moment when external vendors are commonly selected or expanded (spec §70).
Why nowClinicalTrials.gov record updated 148 days ago.
ConfidenceHigh · 95%